Delivery Order SPE2DX15D3003-SPE2DX24F5M0E
Award Date 3/4/24
Potential Completion Date 3/5/24
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract (SPE2DX15D1053|SPE2DX24F6JVZ) worth $19,567.07 by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product XELJANZ XR 11 MG TABLET UU 30S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order under contract SPE2DX15D2215 with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for Xeljanz XR 11 mg tablets, a specialty pharmaceutical, with a ceiling value of $17,366.29 and a firm fixed price. This delivery order is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order under contract SPE2DX15D3020 from the Defense Logistics Agency (DLA) Troop Support Medical. The $2,927.27 firm fixed price order is for the delivery of Xeljanz XR 11 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $3,331.49 by the Defense Logistics Agency (DLA) to provide XELJANZ 10 MG TABLET UU 60S. The contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities....
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $24,676.40, is for the delivery of XELJANZ XR 11 MG TABLET in quantities of 30s. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded Delivery Order SPE2DX24F3QLY as a prime contractor to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price contract, with a ceiling value of $5,077.01, is for the delivery of XELJANZ 10 MG TABLET UU 60S pharmaceutical products. No set-aside designation was used for this award. Amerisourcebergen Drug Corp has also been awarded an indefinite delivery contract (IDC) by DLA, with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,484.55 firm-fixed-price delivery order is for the supply of Xeljanz 5 mg tablets and has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,164.32, is for the delivery of Xeljanz XR 11 mg tablets over a period ending on April 23, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 mg tablets. The potential value of this delivery order is $3,014.72 and the period of performance extends through February 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, is a firm fixed price delivery order for the supply of the medication XELJANZ XR 11 MG TABLET in 30-count packages. The contract, with a ceiling value of $8,490.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery...